Phosphodiesterase Type 5 Expression in Human and Rat Lower Urinary Tract Tissues and the Effect of Tadalafil on Prostate Gland Oxygenation in Spontaneously Hypertensive Rats-Reference-Cited by-同舟云学术

Phosphodiesterase Type 5 Expression in Human and Rat Lower Urinary Tract Tissues and the Effect of Tadalafil on Prostate Gland Oxygenation in Spontaneously Hypertensive Rats

Published:2011-10 Issue:10 Volume:8 Page:2746-2760
ISSN:1743-6095
Container-title:The Journal of Sexual Medicine
language:en
Short-container-title:The Journal of Sexual Medicine

Author:

Morelli Annamaria,Sarchielli Erica,Comeglio Paolo,Filippi Sandra,Mancina Rosa,Gacci Mauro,Vignozzi Linda,Carini Marco,Vannelli Gabriella B.,Maggi Mario

Publisher

Elsevier BV

Subject

Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

Reference54 articles.

1. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: A randomized, double‐blind trial;McVary;J Urol,2007

2. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia;McVary;J Urol,2007

3. Sildenafil citrate improves erectile function and lower urinary tract symptoms independent of baseline body mass index or LUTS severity;McVary;Urology,2008

4. A randomised, placebo‐controlled study to assess the efficacy of twice‐daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia;Stief;Eur Urol,2008

5. Vardenafil can improve continence recovery after bilateral nerve sparing prostatectomy: Results of a randomized, double blind, placebo‐controlled pilot study;Gacci;J Sex Med,2010

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing monotherapy with tadalafil or tamsulosin in men with benign prostatic hyperplasia: A case–control study;Journal of Advanced Pharmaceutical Technology & Research;2024-07

2. Comparative study of tamsulosin, tadalafil, and combination of tamsulosin with tadalafil in the treatment of patients with lower urinary tract symptoms;Urological Science;2024-06

3. Early investigational agents for the treatment of benign prostatic hyperplasia’;Expert Opinion on Investigational Drugs;2024-03-04

4. Insights into the associative role of hypertension and angiotensin II receptor in lower urinary tract dysfunction;Hypertension Research;2024-02-14

5. Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives;International Journal of Molecular Sciences;2023-10-24